3.34 USD
0 (0%)
We assign a fundamental rating of 3 out of 10 to HHS. HHS was compared to 94 industry peers in the Media industry. HHS has only an average score on both its financial health and profitability. HHS has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year HHS has reported negative net income.
In the past year HHS had a positive cash flow from operations.
In multiple years HHS reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: HHS reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -5.88%, HHS is in line with its industry, outperforming 41.49% of the companies in the same industry.
The Return On Equity of HHS (-27.40%) is comparable to the rest of the industry.
The Return On Invested Capital of HHS (5.20%) is better than 68.09% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HHS is above the industry average of 7.16%.
The last Return On Invested Capital (5.20%) for HHS is well below the 3 year average (11.42%), which needs to be investigated, but indicates that HHS had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.88% | ||
| ROE | -27.4% | ||
| ROIC | 5.2% |
ROA(3y)-0.52%
ROA(5y)1.66%
ROE(3y)13.57%
ROE(5y)N/A
ROIC(3y)11.42%
ROIC(5y)N/A
1.3 Margins
The Operating Margin of HHS (2.35%) is comparable to the rest of the industry.
HHS's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 18.47%, HHS is not doing good in the industry: 75.53% of the companies in the same industry are doing better.
HHS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.35% | ||
| PM (TTM) | N/A | ||
| GM | 18.47% |
OM growth 3Y-16.84%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.08%
GM growth 5Y15.62%
2. Health
2.1 Basic Checks
HHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
HHS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HHS has been increased compared to 5 years ago.
Compared to 1 year ago, HHS has a worse debt to assets ratio.
2.2 Solvency
HHS has an Altman-Z score of 14.60. This indicates that HHS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of HHS (14.60) is better than 96.81% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that HHS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, HHS belongs to the top of the industry, outperforming 81.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 14.6 |
ROIC/WACC0.6
WACC8.73%
2.3 Liquidity
A Current Ratio of 1.48 indicates that HHS should not have too much problems paying its short term obligations.
HHS has a Current ratio of 1.48. This is in the better half of the industry: HHS outperforms 60.64% of its industry peers.
HHS has a Quick Ratio of 1.48. This is a normal value and indicates that HHS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.48, HHS is doing good in the industry, outperforming 60.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.48 |
3. Growth
3.1 Past
HHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.06%, which is quite impressive.
The Revenue for HHS has decreased by -11.07% in the past year. This is quite bad
The Revenue has been decreasing by -3.17% on average over the past years.
EPS 1Y (TTM)82.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1705.73%
Revenue 1Y (TTM)-11.07%
Revenue growth 3Y-1.63%
Revenue growth 5Y-3.17%
Sales Q2Q%-17.03%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y131.2%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.05%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
HHS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 3.09, which indicates a rather cheap valuation of HHS.
95.74% of the companies in the same industry are more expensive than HHS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 24.01. HHS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 3.09 |
4.2 Price Multiples
96.81% of the companies in the same industry are more expensive than HHS, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.21 |
4.3 Compensation for Growth
HHS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for HHS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:HHS (12/23/2025, 11:10:06 AM)
3.34
0 (0%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners31.83%
Inst Owner Change-5.45%
Ins Owners38.17%
Ins Owner Change0%
Market Cap24.75M
Revenue(TTM)166.84M
Net Income(TTM)-5.45M
Analysts80
Price TargetN/A
Short Float %0.94%
Short Ratio0.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 3.09 | ||
| P/S | 0.15 | ||
| P/FCF | N/A | ||
| P/OCF | 15.73 | ||
| P/B | 1.24 | ||
| P/tB | 1.29 | ||
| EV/EBITDA | 2.21 |
EPS(TTM)-0.74
EYN/A
EPS(NY)1.08
Fwd EY32.36%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.21
OCFY6.36%
SpS22.52
BVpS2.68
TBVpS2.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.88% | ||
| ROE | -27.4% | ||
| ROCE | 6.58% | ||
| ROIC | 5.2% | ||
| ROICexc | 5.83% | ||
| ROICexgc | 5.91% | ||
| OM | 2.35% | ||
| PM (TTM) | N/A | ||
| GM | 18.47% | ||
| FCFM | N/A |
ROA(3y)-0.52%
ROA(5y)1.66%
ROE(3y)13.57%
ROE(5y)N/A
ROIC(3y)11.42%
ROIC(5y)N/A
ROICexc(3y)13.82%
ROICexc(5y)N/A
ROICexgc(3y)14.26%
ROICexgc(5y)N/A
ROCE(3y)14.46%
ROCE(5y)N/A
ROICexgc growth 3Y-19.31%
ROICexgc growth 5YN/A
ROICexc growth 3Y-19.72%
ROICexc growth 5YN/A
OM growth 3Y-16.84%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.08%
GM growth 5Y15.62%
F-Score6
Asset Turnover1.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.06 | ||
| Cap/Depr | 42.41% | ||
| Cap/Sales | 1.18% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 18.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.48 | ||
| Altman-Z | 14.6 |
F-Score6
WACC8.73%
ROIC/WACC0.6
Cap/Depr(3y)122.2%
Cap/Depr(5y)111.4%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1705.73%
EPS Next Y131.2%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.07%
Revenue growth 3Y-1.63%
Revenue growth 5Y-3.17%
Sales Q2Q%-17.03%
Revenue Next Year4.05%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-57.16%
EBIT growth 3Y-18.2%
EBIT growth 5YN/A
EBIT Next Year198.68%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-103.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-87.52%
OCF growth 3YN/A
OCF growth 5YN/A
HARTE-HANKS INC / HHS FAQ
What is the ChartMill fundamental rating of HARTE-HANKS INC (HHS) stock?
ChartMill assigns a fundamental rating of 3 / 10 to HHS.
What is the valuation status of HARTE-HANKS INC (HHS) stock?
ChartMill assigns a valuation rating of 4 / 10 to HARTE-HANKS INC (HHS). This can be considered as Fairly Valued.
What is the profitability of HHS stock?
HARTE-HANKS INC (HHS) has a profitability rating of 4 / 10.
What is the earnings growth outlook for HARTE-HANKS INC?
The Earnings per Share (EPS) of HARTE-HANKS INC (HHS) is expected to grow by 131.2% in the next year.
Is the dividend of HARTE-HANKS INC sustainable?
The dividend rating of HARTE-HANKS INC (HHS) is 0 / 10 and the dividend payout ratio is 0%.